Mustang Bio Email Format

Biotechnology ResearchMassachusetts, United States11-50 Employees

Mustang Bio, Inc. is a clinical-stage biotechnology company focused on translating advances in cell therapies into potential cures for difficult-to-treat cancers. It aims to acquire rights to promising technologies through licensing or ownership stakes in order to fund research and development and then outlicense or bring the therapies to market. The company has partnered with leading medical institutions to advance CAR-T therapies, leveraging collaborations to progress its clinical programs. Mustang Bio was founded by Fortress Biotech, Inc., and its common stock is registered under the Securities Exchange Act of 1934, with periodic reports filed with the SEC.

Headquartered in Worcester, Massachusetts, the company has expanded its footprint within the region, including a relocation of its corporate headquarters to Waltham in 2025. These moves reflect an ongoing effort to grow its operational presence while maintaining a focus on developing cell-therapy approaches for cancer.

Sign up for free to view info

Company overview Employee directory